ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions

A Bourdin, L Bjermer, C. Brightling, G. Brusselle, P. Chanez, F. Chung, A. Custovic, Z. Diamant, S. Diver, R. Djukanovic, Dermot Ryan

Research output: Contribution to journalArticlepeer-review

Abstract

Despite the use of effective medications to control asthma, severe exacerbations in asthma are still a major health risk and require urgent action on the part of the patient and physician to prevent a serious outcome such as hospitalisation or death. Moreover, severe exacerbations are associated with substantial huge healthcare costs, and psychological burden including anxiety and fear for patients and their families. The European Academy of Allergy and Clinical Immunology (EAACI) and the European Respiratory Society (ERS) set up a Task Force (TF) to search for a clear definition of severe exacerbations and to also define research questions and priorities. The statement includes comments from patients who were members of the TF.
Original languageEnglish
Article number1900900
JournalEuropean Respiratory Journal
Volume54
Issue number3
Early online date28 Sep 2019
DOIs
Publication statusE-pub ahead of print - 28 Sep 2019

Fingerprint

Dive into the research topics of 'ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions'. Together they form a unique fingerprint.

Cite this